These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30924090)

  • 61. Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion.
    Yuan T; Liao W; Feng NH; Lou YL; Niu X; Zhang AJ; Wang Y; Deng ZF
    Stem Cell Res Ther; 2013 Jun; 4(3):73. PubMed ID: 23769173
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
    Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
    Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Equine Induced Pluripotent Stem Cell Culture.
    Falk J; Donadeu FX
    Methods Mol Biol; 2024; 2749():175-184. PubMed ID: 38133784
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
    Yoshida Y; Yamanaka S
    Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Induced Pluripotent Stem Cells: A New Frontier for Stem Cells in Dentistry.
    Hynes K; Menichanin D; Bright R; Ivanovski S; Hutmacher DW; Gronthos S; Bartold PM
    J Dent Res; 2015 Nov; 94(11):1508-15. PubMed ID: 26285811
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A comparison of stem cells for therapeutic use.
    Rodgerson DO; Harris AG
    Stem Cell Rev Rep; 2011 Nov; 7(4):782-96. PubMed ID: 21365257
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Embryonic stem cells in science and medicine, part II: law, ethics, and the continuing need for dialogue.
    Solomon LM; Brockman-Lee SA
    Gend Med; 2008 Mar; 5(1):3-9. PubMed ID: 18420161
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of histocompatible primate-induced pluripotent stem cells for neural transplantation.
    Deleidi M; Hargus G; Hallett P; Osborn T; Isacson O
    Stem Cells; 2011 Jul; 29(7):1052-63. PubMed ID: 21608081
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Progress and prospects in stem cell therapy.
    Xu XL; Yi F; Pan HZ; Duan SL; Ding ZC; Yuan GH; Qu J; Zhang HC; Liu GH
    Acta Pharmacol Sin; 2013 Jun; 34(6):741-6. PubMed ID: 23736002
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pluripotent stem cell applications for regenerative medicine.
    Angelos MG; Kaufman DS
    Curr Opin Organ Transplant; 2015 Dec; 20(6):663-70. PubMed ID: 26536430
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Induced dopaminergic neurons: A new promise for Parkinson's disease.
    Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
    Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The embryonic stem cells research. Example of biotechnology progress under extra-scientific pressure].
    Gámez Escalona JA
    Cuad Bioet; 2013; 24(82):443-62. PubMed ID: 24483318
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Embryonic and induced pluripotent stem cells: understanding, creating, and exploiting the nano-niche for regenerative medicine.
    Kingham E; Oreffo RO
    ACS Nano; 2013 Mar; 7(3):1867-81. PubMed ID: 23414366
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Induced pluripotent stem cell consensus genes: implication for the risk of tumorigenesis and cancers in induced pluripotent stem cell therapy.
    Zhang G; Shang B; Yang P; Cao Z; Pan Y; Zhou Q
    Stem Cells Dev; 2012 Apr; 21(6):955-64. PubMed ID: 22185567
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation.
    Lewandowski J; Kurpisz M
    Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):349-70. PubMed ID: 26939778
    [TBL] [Abstract][Full Text] [Related]  

  • 78. History and current status of clinical studies using human pluripotent stem cells.
    Kobold S; Bultjer N; Stacey G; Mueller SC; Kurtz A; Mah N
    Stem Cell Reports; 2023 Aug; 18(8):1592-1598. PubMed ID: 37028422
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Potential of Induced Pluripotent Stem Cells for Use in Gene Therapy: History, Molecular Bases, and Medical Perspectives.
    Fus-Kujawa A; Mendrek B; Trybus A; Bajdak-Rusinek K; Stepien KL; Sieron AL
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067183
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Scientific and ethical issues related to stem cell research and interventions in neurodegenerative disorders of the brain.
    Barker RA; de Beaufort I
    Prog Neurobiol; 2013 Nov; 110():63-73. PubMed ID: 23665410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.